LIMK2 and non-small cell lung carcinoma: Xu et al. found that MED12 knockdown activates LIMK2, causing abnormal remodeling of the actin cytoskeleton, disrupting the shedding of intercellular bridges, and leading to cytokinesis failure, thereby inhibiting NSCLC cell proliferation [238].